Substrates for Post-Stroke Arm Rehabilitation
SPARk
Defining the Neurological Substrates of Proximal Upper Extremity Motor Control and Recovery After Stroke
2 other identifiers
interventional
50
1 country
1
Brief Summary
Difficulty moving the arm is very common and a major cause of disability after stroke. Although rehabilitation therapies (i.e., occupational and physical therapy) are the most common treatments used to improve arm motor function, it remains unknown how therapy actually changes brain pathways after stroke. This project seeks to generate fundamental knowledge about brain pathways that allow people to move their arm after stroke and how these pathways change with rehabilitation; we expect this knowledge to translate to new therapies to reduce stroke-related disability. We plan to enroll N = 50 patients with moderate to severe difficulty moving their arm after ischemic or hemorrhage stroke during the subacute period (3 to 6 months post stroke) into either 30 hours over 6 weeks of Arm Basis Training (a protocolized form of occupational therapy targeting motor control) or usual care. We will perform kinematic motor assessments, neuroimaging, and neurophysiology before and after therapy in order to test the hypothesis that intensive, target training improves arm motor control and induces corresponding anatomical and physiological changes of associated brain pathways.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2025
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 22, 2025
CompletedFirst Posted
Study publicly available on registry
May 31, 2025
CompletedStudy Start
First participant enrolled
October 7, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 30, 2030
March 11, 2026
March 1, 2026
4.6 years
May 22, 2025
March 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in Kinematic Measure of Upper Extremity Motor Control
Kinematic measures of Upper Extremity Motor Control include joint individuation index (a measure of how well joints can move independently of other joints) and shoulder-elbow coordination (a measure of how normal a point-to-point planar reaching movement is)
Pre- and post- 6 weeks of therapy
Change in Corticospinal Tract Axon Density on MRI
High-resolution diffusion MR neuroimaging will be performed, from which corticospinal tract axon density will be calculated
Pre- and post- 6 weeks of therapy
Change in Corticospinal Tract Neurophysiology
The primary neurophysiologic measure of interest will be MEP presence or absence at proximal upper extremity muscles. If MEP positive, secondary measures of corticospinal excitability will be the MEP recruitment curve slope as well as MEP amplitude (at 100% MSO).
Pre- and post- six weeks of therapy
Study Arms (2)
Arm Basis Training
EXPERIMENTALThis program is a systematic training regimen specifically designed to improve proximal motor control for patients with severe upper extremity hemiparesis. The core principles of the Arm Basis Training Program focus on rebuilding the fundamental capacity for specific and selective motor control before progressing to more complex motor patterns.
Usual Care Occupational Therapy
NO INTERVENTIONUsual care occupational therapy. Participants will be asked to keep logs of the therapy they receive.
Interventions
This program is a systematic training regimen specifically designed to improve proximal motor control for patients with severe upper extremity hemiparesis. The core principles of the Arm Basis Training Program focus on rebuilding the fundamental capacity for specific and selective motor control before progressing to more complex motor patterns.
Eligibility Criteria
You may qualify if:
- first time unilateral ischemic or hemorrhagic stroke occurring within the 3-6 months
- upper extremity motor impairment as measured by the Upper Extremity Fugl-Meyer Assessment (UE-FMA) Score \<= 44
- ability to participate in a 6-week intensive upper extremity intervention in English as determined by a licensed occupational therapist.
You may not qualify if:
- bilateral stroke
- unstable medical status affecting functional status
- pre-stroke upper extremity injury or conditions that limited use
- visual or auditory impairment limiting ability to participate in study procedures
- significant aphasia (NIHSS sub-item 9 \> 1) or cognitive (NIHSS 1a or 1b or
- c \> 1) deficits
- known or expected inability to maintain follow-up through the study intervention and post- assessment
- contraindications to MRI
- contraindications to TMS
- known history of uncontrolled seizure disorder.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Laboratory for Translational Neurorecovery, Center for Neurotechnology and Neurorecovery, Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David J Lin, MD
Massachusetts General Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Neurologist
Study Record Dates
First Submitted
May 22, 2025
First Posted
May 31, 2025
Study Start
October 7, 2025
Primary Completion (Estimated)
April 30, 2030
Study Completion (Estimated)
April 30, 2030
Last Updated
March 11, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- May 2031 -
- Access Criteria
- We will give database access to investigators who contact us about specific projects or analyses and/or are willing to enter into the same data sharing, authorship, and human subject data protection protocols that binds our multi-institutional collaboration, and agree to work closely with us to ensure that these complex data are analyzed with complete understanding of the experimental conditions under which they were collected.
1. We will release raw behavior, imaging, and physiology data sets with relevant de-identified data to the database \~12 months after we have finished a portion of the project with enough sample size for publication. We will give database access to investigators who contact us about specific projects or analyses and/or are willing to enter into the same data sharing, authorship, and human subject data protection protocols that binds our multi-institutional collaboration, and agree to work closely with us to ensure that these complex data are analyzed with complete understanding of the experimental conditions under which they were collected. 2. We will also release annotated, preprocessed datasets from this grant that form the basis for published manuscripts two years after their initial (online) publication date. We will make data available to individuals who agree to a data-sharing agreement.